stockrowQuest Diagnostics Incorporated
DGX Healthcare Diagnostics & Research
Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024.
- Revenue
- +9.98%
- EPS
- +29.4%
- Free cash flow
- +6.21%
- Total debt
- −2.20%
Quarter to September 2026, against a year earlier
Follow DGX
Alert me
Quest Diagnostics Incorporated (DGX) Return on invested capital
Quest Diagnostics Incorporated's return on invested capital over the twelve months to 30 September 2026 was 8.48%, up 0.7 percentage points from fiscal 2025 (7.81%). Over the past ten years it has ranged from 6.74% (fiscal 2024) to 15.5% (fiscal 2021); the current reading is higher than 36% of that period. That is above the Diagnostics & Research industry median of 0.00% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 7.81% | 1.07 |
| FY2024 | 6.74% | (0.87) |
| FY2023 | 7.61% | (1.69) |
| FY2022 | 9.30% | (6.16) |
| FY2021 | 15.5% | 2.72 |
| FY2020 | 12.7% | 4.44 |
| FY2019 | 8.30% | 0.68 |
| FY2018 | 7.62% | (0.84) |
| FY2017 | 8.46% | (1.47) |
| FY2016 | 9.93% | (0.69) |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| MTD Mettler-Toledo International, Inc. compare | 35.4% |
| ILMN Illumina, Inc. compare | 16.7% |
| DGX Quest Diagnostics Incorporated | 8.48% |
| IQV IQVIA Holdings Inc. compare | 6.79% |
| LH Labcorp Holdings Inc. compare | 6.76% |
| RVTY Revvity Inc. compare | 2.50% |
| WAT Waters Corporation compare | 1.13% |
| MEDP Medpace Holdings, Inc. compare | 0.00% |
| GH Guardant Health, Inc. compare | −25.7% |
| Diagnostics & Research industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on DGX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement